A Study of CS1003 in Subjects With Advanced Solid Tumors

NCT03475251 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

BIOLOGICAL: CS1003
BIOLOGICAL: CS1003
DRUG: Regorafenib

Sponsor

CStone Pharmaceuticals